Cleared Traditional

K233760 - Mjolnir Pro. (Multi–electrode plasma) (FDA 510(k) Clearance)

Feb 2024
Decision
88d
Days
Class 2
Risk

K233760 is an FDA 510(k) clearance for the Mjolnir Pro. (Multi–electrode plasma). This device is classified as a Low Power Electrosurgical Devices For Skin Lesion Destruction (Class II - Special Controls, product code QVJ).

Submitted by Shenzhen Leaflife Technology Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on February 20, 2024, 88 days after receiving the submission on November 24, 2023.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4400. For The Removal And Destruction Of Skin Lesions In General Dermatological Procedures, Also Referred To As Plasma Pen Devices, Which Generates Electrical Arc In The Ambient Air Between An Electrical Probe Tip And The Skin And Cause Intended Tissue Damage For The Removal And Destruction Of Skin Lesions.

Submission Details

510(k) Number K233760 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 24, 2023
Decision Date February 20, 2024
Days to Decision 88 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code QVJ - Low Power Electrosurgical Devices For Skin Lesion Destruction
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4400
Definition For The Removal And Destruction Of Skin Lesions In General Dermatological Procedures, Also Referred To As Plasma Pen Devices, Which Generates Electrical Arc In The Ambient Air Between An Electrical Probe Tip And The Skin And Cause Intended Tissue Damage For The Removal And Destruction Of Skin Lesions